Over-expression of HER2 is generally seen in high grade breast cancers and is associated with aggressive tumour growth characteristics including increased proliferation [3], enhanced tumorigenicity [4] and metastatic potential [5]. This evidence concerns the gene ERBB2 and neoplasm.